LIAISON® Hepatitis Diagnostic Solution
Viral hepatitis discrimination is a challenge for clinicians and can impact the correct treatment choice for patient.
The comprehensive diagnostic panel for hepatitis A, hepatitis B, and hepatitis C increases diagnostic efficiency, optimizes resources and helps limit chronic medical conditions.
LIAISON® Anti-HAV
Qualitative immunoassay for total Anti-HAV antibodies determination as an aid in the HAV infection diagnosis in individuals with or without symptoms of hepatitis.
LIAISON® HAV IgM
Qualitative immunoassay for HAV IgM antibodies determination as an aid in the diagnosis of acute or recent HAV infection.
LIAISON® Murex HBsAg & LIAISON XL Murex HBsAg Confirmatory
Qualitative immunoassay for HBsAg determination as an aid in HBV diagnosis and blood and post-mortem donor screening.
LIAISON® Anti-HBc
Qualitative immunoassay for total anti-HBc determination as an aid in HBV diagnosis, blood and post-mortem donor screening.
LIAISON® HBc IgM
Qualitative determination of HBc IgM antibodies as an aid in the diagnosis of acute or recent HBV infection.
LIAISON® XL MUREX Anti-HBs
Quantitative immunoassay for anti-HBs determination as an aid in HBV diagnosis and to evaluate amount of Anti-HBs.
LIAISON® Anti-HBe
Qualitative immunoassay for anti-HBe determination as an aid in HBV diagnosis and in disease status monitoring.
LIAISON® HBeAg
Quantitative immunoassay for HBeAg determination as an aid in HBV diagnosis and in disease status monitoring.
LIAISON® XL Murex HCV Ab
Qualitative immunoassay for HCV Ab determination as an aid in HCV diagnosis, blood and post-mortem donor screening.
Background
Viral hepatitis is a global challenge and it is associated with significant morbidity and mortality.
The initial inflammation of the liver can progress to more serious medical conditions, including hepatocellular carcinoma. Prevention of widespread transmission necessitates accurate, early diagnosis and patient follow-up.
Diasorin is committed to helping clinicians and laboratories by optimizing first-line virological evaluation of acute hepatitis infection through differentiation of Hepatitis A, Hepatitis B, Hepatitis C.
How it works
The LIAISON® Hepatitis Diagnostic Solution is the first automated, high-throughput solution to determine all variants from one sample.
Viral differentiation
Easily identify the five hepatitis types from a single patient sample.
Accurate mutants detection
Antibodies directed to highly conserved epitopes of HBsAg inner region that can detect mutant forms of HBsAg.
Why use LIAISON® Hepatitis Diagnostic Solution
Specialized qualitative and quantitative testing.
LIAISON® HBeAg
The value of HBeAg quantification for diagnosis and monitoring patient with chronic HBV infection.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.